Prosecution Insights
Last updated: April 19, 2026

Prosyla Group Pc

14 pending office actions • 9 clients

Portfolio Summary

14
Total Pending OAs
2
Final Rejections
12
Non-Final OAs

Client Portfolio (9 clients)

Client (Assignee)Pending OAs
Academia Sinica 4
Eg Biomed Co., Ltd. 2
Rock Biomedical Inc. 2
Mycomagic Biotechnology Co., Ltd. 1
Taipei Medical University 1
China Medical University 1
Obi Pharma, Inc. 1
Yoda Therapeutics Inc. 1
Ming-Tain Lai 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18884500 Untitled Academia Sinica THOMAS, COURTNEY D 2884 Non-Final OA
18977532 METHOD FOR EARLY DETECTION, PREDICTION OF TREATMENT RESPONSE AND PROGNOSIS OF LUNG CANCER Eg Biomed Co., Ltd. SALMON, KATHERINE D 1682 Non-Final OA Dec 11, 2024
18792473 EXOSOME COMPOSITION CONTAINING GANODERMA IMMUNOMODULATORY PROTEIN AND USES THEREOF Mycomagic Biotechnology Co., Ltd. RICCI, CRAIG D 1611 Non-Final OA Aug 01, 2024
18747694 CELLS FOR GLYCOENGINEERING AND METHODS OF USE Rock Biomedical Inc. PERSONS, JENNA L 1637 Non-Final OA Jun 19, 2024
18629722 METHODS AND COMPOSITIONS FOR DENDRITIC CELL TARGETING VACCINES Rock Biomedical Inc. VYAS, KEYUR ANILKUMAR 1637 Non-Final OA Apr 08, 2024
18477022 INDOLINE DERIVATIVES FOR TREATMENT AND/OR PREVENTION OF TUMOR OR CELL PROLIFERATIVE AND FIBROSIS DISEASES Taipei Medical University VALLE, ERNESTO 1623 Non-Final OA Sep 28, 2023
18335897 NANOCAPSULE AND USES THEREOF China Medical University BAEK, JONGHWAN NMN 1618 Non-Final OA Jun 15, 2023
18253662 USE OF CRASSOCEPHALUM RABENS EXTRACT IN THE PREVENTION AND/OR TREATMENT OF FATIGUE AND/OR DEPRESSION Academia Sinica CAIN, JENNIFER LYNN 1655 Non-Final OA May 19, 2023
18253576 ACTIVE CANCER IMMUNOTHERAPY BY IMMUNE MODULATION VIA GLOBO SERIES ANTIGENS Obi Pharma, Inc. HAM, JIEUN 1643 Non-Final OA May 18, 2023
18146873 ANTIBODY SPECIFIC TO SPIKE PROTEIN OF SARS-COV-2 AND USES THEREOF Academia Sinica BUCKMASTER, MARLENE VRENI 1672 Non-Final OA Dec 27, 2022
17997490 METHOD FOR EARLY DETECTION, PREDICTION OF TREATMENT RESPONSE AND PROGNOSIS OF COLORECTAL CANCER Eg Biomed Co., Ltd. SALMON, KATHERINE D 1682 Non-Final OA Oct 28, 2022
17808476 BENZIMIDAZOLE DERIVATIVES FOR TREATMENT AND/OR PREVENTION OF DISEASES AND DISORDERS MEDIATED BY NLRP3 Yoda Therapeutics Inc. ABDALHAMEED, MANAHIL MIRGHANI ALI 1622 Final Rejection Jun 23, 2022
17806932 METHOD AND BIOMARKER FOR DETECTION OR DIAGNOSIS OF MYOCARDIAL INFARCTION Academia Sinica HORTH, LISA ANNE 1681 Final Rejection Jun 14, 2022
17595830 COMPANION DIAGNOSTIC ASSAY FOR GLOBO-H RELATED CANCER THERAPY Ming-Tain Lai COUNTS, GARY W 1678 Non-Final OA Nov 24, 2021

Managing Prosyla Group Pc's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month